The topic of this article may not meet Misplaced Pages's general notability guideline. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "Quantitative Biosciences Institute" – news · newspapers · books · scholar · JSTOR (June 2022) (Learn how and when to remove this message) |
The Quantitative Biosciences Institute (QBI) was established in 2016 as an organized research unit (ORU) within the School of Pharmacy at the University of California-San Francisco. The current director of QBI is Nevan Krogan.
History
In 1993, Irwin Kuntz, created an ORU within the School of Pharmacy, called the Molecular Design Institute (MDI). The Dean of the School of Pharmacy, B. Joseph Guglielmo with the support of the UCSF campus and the UC Office of the President transformed MDI into QBI.
Previously, QBI was a part of QB3, also known as QB3-UCSF. In March 2016, UCSF established QBI as a Organized Research Unit (ORU) within the School of Pharmacy.
QBI Coronavirus Research Group
The institute formed the QBI Coronavirus Research Group (QCRG), a collaborative group of labs, aimed at finding solutions for COVID-19.
References
- ^ Fagone, Jason (2020-04-30). "UCSF team has discovered drugs that block coronavirus, paving way for 'a better drug sooner'". San Francisco Chronicle. Retrieved 2022-02-01.
- ^ Fagone, By Jason (2020-05-01). "Cracking the coronavirus: How UCSF scientists raced to decode the deadly disease". San Francisco Chronicle. Retrieved 2022-02-01.
- "Serendipitous Discovery Leads to a New Understanding of How Cells Multitask". Lab Manager. Retrieved 2022-02-01.
- ^ "QBI". QB3. Retrieved 2022-02-01.
- ^ "UCSF Establishes Quantitative Biosciences Institute | UC San Francisco". www.ucsf.edu. 16 March 2016. Retrieved 2022-02-01.
- "eFFECTOR and QBI to study anti-viral agent for Covid-19 treatment". Pharmaceutical Technology. 2021-05-05. Retrieved 2022-02-01.
- "Alpha Coronavirus Variant Evolved to Evade Immune System | UC San Francisco". www.ucsf.edu. 28 December 2021. Retrieved 2022-02-01.
- "How UC fought COVID-19 in 2020". University of California. 2021-01-13. Retrieved 2022-02-01.
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |
This California-related article is a stub. You can help Misplaced Pages by expanding it. |
This pharmacy-related article is a stub. You can help Misplaced Pages by expanding it. |